| 4 | Statement of changes in beneficial owner... | Alles Mark J | Donnelley Financial Solutions File16 /fa | 09/19/2023 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 09/19/2023 | |
| 4 | Statement of changes in beneficial owner... | Alles Mark J | Donnelley Financial Solutions File16 /fa | 06/02/2023 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 06/02/2023 | |
| 4 | Statement of changes in beneficial owner... | Alles Mark J | Donnelley Financial Solutions File16 /fa | 05/24/2023 | |
| 4 | Statement of changes in beneficial owner... | Biomarin Pharmaceutical Inc | Donnelley Financial Solutions File16 /fa | 05/24/2023 | |
| 4 | Statement of changes in beneficial owner... | Biomarin Pharmaceutical Inc | Broadridge Financial Solutions, Inc./fa | 11/02/2022 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 09/19/2022 | |
| 4 | Statement of changes in beneficial owner... | Turning Point Therapeutics, Inc. | Donnelley Financial Solutions File16 /fa | 08/17/2022 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 06/02/2022 | |
| Load More |